Welcome to medications.com

Novartis' ex-chief does U-turn back to J&J - The Star-Ledger - NJ.com

Between 2006 and 2007, generic competition in the United States shaved a cumulative $1 billion off sales of the high blood pressure drug Lotrel, ...

http://www.nj.com/business/ledger... | Posted: Fri Feb 15 00:41:52 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com